Navigation Links
Study improves understanding of surface molecules in controlling size of gold nanoparticles
Date:6/18/2012

North Carolina State University researchers have shown that the "bulkiness" of molecules commonly used in the creation of gold nanoparticles actually dictates the size of the nanoparticles with larger so-called ligands resulting in smaller nanoparticles. The research team also found that each type of ligand produces nanoparticles in a particular array of discrete sizes.

"This work advances our understanding of nanoparticle formation, and gives us a new tool for controlling the size and characteristics of gold nanoparticles," says Dr. Joseph Tracy, an assistant professor of materials science and engineering at NC State and co-author of a paper describing the research. Gold nanoparticles are used in industrial chemical processes, as well as medical and electronics applications.

When creating gold nanoparticles, scientists often use organic molecules called ligands to facilitate the process. The ligands effectively bring gold atoms together in a solution to create the nanoparticles. In the process, ligands essentially line up side by side and surround the nanoparticles in all three dimensions.

The researchers wanted to see whether the bulkiness of the ligands affected nanoparticle size, and opted to assess three types of thiol ligands a family of ligands commonly used to synthesize gold nanoparticles. Specifically, the molecules bound to the gold nanoparticles are linear hexanethiolate (-SC6), cyclohexanethiolate (-SCy) and 1-adamantanethiolate (-SAd). Each of these ligands has a bulkier configuration than the last.

For example, picture each ligand as a slice of pie, with a gold atom attached to the pointed end. -SC6 looks like a very narrow slice of pie. -SCy is slightly larger, and -SAd is the largest of the three with the "crust" end of the pie wedge far wider than the pointed end.

The researchers found that the bulkiness of the ligands determined the size of the nanoparticles. Because fewer -SAd and -SCy ligands can line up next to each other in three dimensions, fewer gold atoms are brought together in the core. Therefore, the nanoparticles are smaller. -SC6, the least bulky of the thiolates, can create the largest nanoparticles.

"While we've shown that this is an effective means of controlling size in gold nanoparticles, we think it may have implications for other materials as well," says Peter Krommenhoek, a Ph.D. student at NC State and lead author of the paper. "That's something we're exploring."

But the researchers made another interesting finding as well.

When particularly small nanoparticles form, they tend to form at very specific sizes, called discrete sizes. For instance, some types of nanoparticles may consist of 25 or 28 atoms but never 26 or 27 atoms.

In this study, the researchers found that the bulkiness of the ligands also changed the discrete sizes of the nanoparticles. "This is interesting, in part, because each discrete size represents a different number of gold atoms and ligands," Tracy says, "which could influence the nanoparticle's chemical behavior. That question has yet to be addressed."


'/>"/>
Contact: Matt Shipman
matt_shipman@ncsu.edu
919-515-6386
North Carolina State University
Source:Eurekalert  

Related biology technology :

1. Positive Clinical Study Results for BSPs HyperQ Technology
2. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
5. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
6. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
7. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
8. Singapore scientists lead human embryonic stem cell study
9. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
10. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
11. Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study improves understanding of surface molecules in controlling size of gold nanoparticles
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:8/23/2017)... 23, 2017  The general public,s help is being enlisted in what,s ... live in and on the human body –and are believed to affect ... The Microbiome Immunity Project is ... starting with the gut. The project's goal is to help advance scientific ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
Breaking Biology News(10 mins):